HART Reports Shareholder Meeting Details

TL;DR

HART held its shareholder meeting on 6/20 to vote on directors. Nothing major changed.

AI Summary

Harvard Apparatus Regenerative Technology, Inc. (HART) filed an 8-K on June 24, 2024, reporting a shareholder meeting held on June 20, 2024. The primary purpose of the meeting was to vote on the election of directors and other corporate matters. The company previously operated under the name Biostage, Inc. before changing its name on March 31, 2016.

Why It Matters

This filing provides transparency on key corporate governance events, including director elections, which can impact the company's strategic direction and investor confidence.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of a shareholder meeting and does not contain significant new financial or operational information.

Key Players & Entities

• Harvard Apparatus Regenerative Technology, Inc. (company) — Registrant
• Biostage, Inc. (company) — Former company name
• June 20, 2024 (date) — Date of shareholder meeting
• June 24, 2024 (date) — Filing date of 8-K

FAQ

Filing Documents

• form8-k.htm (8-K) — 50KB
• 0001493152-24-024931.txt ( ) — 215KB
• hrgn-20240620.xsd (EX-101.SCH) — 3KB
• hrgn-20240620_lab.xml (EX-101.LAB) — 33KB
• hrgn-20240620_pre.xml (EX-101.PRE) — 22KB
• form8-k_htm.xml (XML) — 3KB

From the Filing

UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 20, 2024 HARVARD APPARATUS REGENERATIVE TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-35853 45-5210462 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 84 October Hill Road , Suite 11 , Holliston , MA 01746 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (774) 233-7300 (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: None Title of each class Trading Symbol(s) Name of each exchange on which registered Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 5.07 Submission of Matters to a Vote of Security Holders. On June 20, 2024, Harvard Apparatus Regenerative Technology, Inc., or the Company, held its Annual Meeting of Stockholders, or the Annual Meeting. At the Annual Meeting, the Company's stockholders voted on the following proposals: (i) the election of three Director Nominees as Class II Directors, each nominated by the Board of Directors of the Company for a three-year term, such term to continue until the annual meeting of stockholders in 2027 and until such Director's successor is duly elected and qualified or until their earlier resignation or removal, (ii) the ratification of the appointment of Marcum LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024, and (iii) the non-binding approval of the compensation of the Company's named executive officers. The voting results for the matters submitted to a stockholder vote at the Annual Meeting are reported below. Proposal 1 - Election of Directors On such election of directors proposal, each of David Green, Ting Li, and Ronald Packard were elected as Class II Directors, each for a three-year term, such term to continue until the annual meeting of stockholders in 2027 and until such Director's successor is duly elected and qualified or until their earlier resignation or removal. Due to the plurality election, votes could only be cast in favor of or withheld from the nominee and thus votes against were not applicable. The results of the election were as follows: Name Votes For Votes Withheld Broker Non-Votes David Green 826,014 7,222,665 1,695,472 Ting Li 7,219,675 829,004 1,695,472 Ronald Packard 6,543,481 1,505,198 1,695,472 Proposal 2 – Ratification of the appointment of Marcum LLP as the Company's independent registered public accounting firm for the The ratification of the appointment of Marcum LLP as the Company's independent registered public accounting firm was approved as follows: Votes For Votes Against Votes Abstained Broker Non-Votes 9,738,743 2,678 2,730 0 Proposal 3 – Approval, by Non-Binding Advisory Vote, of the Compensation of the Company's Named Executive Officers The compensation of the Company's named executive officers was approved, by a non-binding advisory vote, as follows: Votes For Votes Against Votes Abstained Broker Non-Votes 8,033,183 14,649 847 0 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HARVARD APPARATUS REGENERATIVE TECHNOLOGY, INC. (Registrant) June 24, 2024 /s/ Junli He (Date) Junli He Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR